Applications for San Francisco (Batch 12) extended AGAIN through September 30th, 2021!

Learn more about investing in Ivy Natal

Our team will get back to you soon to follow up on your inquiry.
Ivy Natal
Unlocking human fertility
* Data source: Crunchbase
Founded
2020
Employees*
1-10
Funding to Date*
$250K
Website
ivynatal.com
Dr. Jeffrey Hsu, CEO
Our goal is to ensure that every person and couple has the choice to have genetic children.
Global infertility rates are between 10-25% -- largely due to disease, stress, and the fragility of human egg cells.

Ivy Natal is developing a process to create healthy human egg cells from skin cells as a treatment for most cases of infertility. Ivy Natal is developing a novel process to create healthy human egg cells from skin cells, giving women the confidence in their ability to choose whether and when to have a child. Many fertility patients cannot have children except through the use of donor eggs. This can be due to surgery, chemotherapy, maternal age, or genetic conditions. Ivy Natal aims to enable these parents to have genetic children for the first time.